Please login to the form below

Not currently logged in
Email:
Password:

Open Health creates new role

Gavin Jones joins the agency as its director of rare disease

Gavin JonesIn order to strengthen their experience and expertise, healthcare communications and market access group Open Health has appointed Gavin Jones into its newly formed role of director of rare disease.

Jones will work in close partnership with all of the Open Health agencies, driving their existing and future partnerships with customers working in rare diseases.

He said: “Having the opportunity to fully utilise my expertise and knowledge in supporting our customers provide patients hope for the future is a fantastic opportunity [and] I’m honoured to be representing Open Health in this important investment.”

Joining the agency with twenty years’ biopharmaceutical industry experience, Jones’ expertise lies in market access, therapy launch and patient centric services.

Commenting on his appointments, Sandy Roydon, chief executive officer of Open Health, said: “We are delighted that Gavin has joined us to further strengthen our partnerships with customers in rare disease.

“Creating a unique role within our field of expertise will enable us to offer a market leading position in supporting our customers work towards greater access and uptake of their innovative and much needed treatments.”

9th March 2018

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics